205 related articles for article (PubMed ID: 17604322)
1. Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells--phosphorylated RXR alpha is a critical target for colon cancer management.
Yamazaki K; Shimizu M; Okuno M; Matsushima-Nishiwaki R; Kanemura N; Araki H; Tsurumi H; Kojima S; Weinstein IB; Moriwaki H
Gut; 2007 Nov; 56(11):1557-63. PubMed ID: 17604322
[TBL] [Abstract][Full Text] [Related]
2. Regulation of retinoic acid receptor beta expression by peroxisome proliferator-activated receptor gamma ligands in cancer cells.
James SY; Lin F; Kolluri SK; Dawson MI; Zhang XK
Cancer Res; 2003 Jul; 63(13):3531-8. PubMed ID: 12839938
[TBL] [Abstract][Full Text] [Related]
3. Proteasome inhibitors induce peroxisome proliferator-activated receptor transactivation through RXR accumulation and a protein kinase C-dependent pathway.
Tsao WC; Wu HM; Chi KH; Chang YH; Lin WW
Exp Cell Res; 2005 Mar; 304(1):234-43. PubMed ID: 15707588
[TBL] [Abstract][Full Text] [Related]
4. Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer.
Park EY; Cho IJ; Kim SG
Cancer Res; 2004 May; 64(10):3701-13. PubMed ID: 15150131
[TBL] [Abstract][Full Text] [Related]
5. RXRgamma and PPARgamma ligands in combination to inhibit proliferation and invasiveness in colon cancer cells.
Papi A; Rocchi P; Ferreri AM; Orlandi M
Cancer Lett; 2010 Nov; 297(1):65-74. PubMed ID: 20510503
[TBL] [Abstract][Full Text] [Related]
6. A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands.
Crowe DL; Chandraratna RA
Breast Cancer Res; 2004; 6(5):R546-55. PubMed ID: 15318936
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor-gamma and retinoic acid X receptor alpha represses the TGFbeta1 gene via PTEN-mediated p70 ribosomal S6 kinase-1 inhibition: role for Zf9 dephosphorylation.
Lee SJ; Yang EK; Kim SG
Mol Pharmacol; 2006 Jul; 70(1):415-25. PubMed ID: 16611854
[TBL] [Abstract][Full Text] [Related]
8. Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor-alpha exert synergistic antiproliferative effects on human coronary artery smooth muscle cells.
Benson S; Padmanabhan S; Kurtz TW; Pershadsingh HA
Mol Cell Biol Res Commun; 2000 Mar; 3(3):159-64. PubMed ID: 10860864
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.
Giaginis C; Katsamangou E; Tsourouflis G; Zizi-Serbetzoglou D; Kouraklis G; Theocharis S
Med Sci Monit; 2009 May; 15(5):BR148-56. PubMed ID: 19396032
[TBL] [Abstract][Full Text] [Related]
10. Retinoid X receptor alpha is highly phosphorylated in retinoic acid-resistant HL-60R cells and the combination of 9-cis retinoic acid plus MEK inhibitor induces apoptosis in the cells.
Kanemura N; Tsurumi H; Okuno M; Matsushima-Nishiwaki R; Shimizu M; Moriwaki H
Leuk Res; 2008 Jun; 32(6):884-92. PubMed ID: 18082883
[TBL] [Abstract][Full Text] [Related]
11. Effect of 9-cis-retinoic acid on growth and RXR expression in human breast cancer cells.
Zhao Z; Zhang ZP; Soprano DR; Soprano KJ
Exp Cell Res; 1995 Aug; 219(2):555-61. PubMed ID: 7641808
[TBL] [Abstract][Full Text] [Related]
12. Enhanced effects of PPARgamma ligands and RXR selective retinoids in combination to inhibit migration and invasiveness in cancer cells.
Papi A; Rocchi P; Ferreri AM; Guerra F; Orlandi M
Oncol Rep; 2009 Apr; 21(4):1083-9. PubMed ID: 19288012
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition.
Avis I; Martínez A; Tauler J; Zudaire E; Mayburd A; Abu-Ghazaleh R; Ondrey F; Mulshine JL
Cancer Res; 2005 May; 65(10):4181-90. PubMed ID: 15899809
[TBL] [Abstract][Full Text] [Related]
14. Selective activation of PPARgamma in breast, colon, and lung cancer cell lines.
Allred CD; Kilgore MW
Mol Cell Endocrinol; 2005 May; 235(1-2):21-9. PubMed ID: 15866424
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of 9-cis-retinoic acid inhibition of adipogenesis in 3T3-L1 cells.
Sagara C; Takahashi K; Kagechika H; Takahashi N
Biochem Biophys Res Commun; 2013 Mar; 433(1):102-7. PubMed ID: 23485459
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of peroxisome proliferator activated receptor-gamma (PPAR gamma) ligands in proximal tubular cells: thiazolidinediones are partial PPAR gamma agonists.
Chana RS; Lewington AJ; Brunskill NJ
Kidney Int; 2004 Jun; 65(6):2081-90. PubMed ID: 15149321
[TBL] [Abstract][Full Text] [Related]
17. Synergistic growth inhibition by 9-cis-retinoic acid plus trastuzumab in human hepatocellular carcinoma cells.
Tatebe H; Shimizu M; Shirakami Y; Tsurumi H; Moriwaki H
Clin Cancer Res; 2008 May; 14(9):2806-12. PubMed ID: 18451248
[TBL] [Abstract][Full Text] [Related]
18. Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development.
Kim MJ; Deplewski D; Ciletti N; Michel S; Reichert U; Rosenfield RL
Mol Genet Metab; 2001 Nov; 74(3):362-9. PubMed ID: 11708867
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism of protection against chemically and gamma-radiation induced apoptosis in human colon cancer cells.
Pierzchalski P; Krawiec A; Gawełko J; Pawlik WW; Konturek SJ; Gonciarz M
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():191-202. PubMed ID: 18812638
[TBL] [Abstract][Full Text] [Related]
20. Retinoid X receptor agonists impair arterial mononuclear cell recruitment through peroxisome proliferator-activated receptor-γ activation.
Sanz MJ; Albertos F; Otero E; Juez M; Morcillo EJ; Piqueras L
J Immunol; 2012 Jul; 189(1):411-24. PubMed ID: 22661092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]